Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Watch Darktrace (DARK) by Gordon Best in The Motley Fool
- Buy Lloyds Banking Group (LLOY) by Harvey Jones in The Motley Fool
- Avoid Ilika (IKA) by Steve Moore in ShareProphets
- Buy Tullow Oil (TLW) by Bank of America
- Underperform InterContinental Hotels Group (IHG) by Bernstein
- Add Rio Tinto (RIO) by Mark David Hartley in The Motley Fool
- Buy Tritax Big Box Reit (BBOX) by Jefferies
- Overweight easyJet (EZJ) by Barclays
- Neutral Weir Group (WEIR) by Redburn
- Buy FRP Advisory Group (FRP) by Berenberg
- Buy Grainger (GRI) by Deutsche Bank
- Hold Ashmore Group (ASHM) by Deutsche Bank
- Buy Porvair (PRV) by Berenberg
- Reduce Antofagasta (ANTO) by HSBC
- Buy BT Group (BT.A) by HSBC
- Overweight Anglo American (AAL) by JP Morgan
- Hold Rio Tinto (RIO) by HSBC
- Hold Glencore (GLEN) by HSBC
- Buy Flutter Entertainment (DI) (FLTR) by Goldman Sachs
- Neutral United Utilities Group (UU.) by Goldman Sachs
Avacta Group (AVCT) Share Price
Health Care Sector
NOTE: This is based on 54 open tips for Avacta Group (AVCT)
| Latest Bid : 42.50p | Latest Ask : 43.00p |
| High Today : 43.62p | Low Today : 42.58p |
| This Years High : 159.60p | This Years Low : 42.58p |
| Volume : 314,131 | MKT Cap : £154.37M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
26/01/2016 – Stock Consolidation 100.000:1.000
Avacta Group (AVCT) Overview
Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION platforms.Avacta Group (AVCT) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Deutsche Bank | Premium Only | 2024-05-07 06:47:00 07/05/2024 | 5.49% |
| Sell | Lucian Miers | Premium Only | 2023-12-24 13:45:00 24/12/2023 | 61.43% |
| Avoid | Kevin Godbold | Premium Only | 2022-10-24 15:35:00 24/10/2022 | 57.43% |
| Sell | Tom Winnifrith | Premium Only | 2022-10-18 14:10:00 18/10/2022 | 55.67% |
| Sell | Cat Jeeves | Premium Only | 2022-10-01 17:20:00 01/10/2022 | 59.62% |
Avacta Group (AVCT) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| GSA Capital Partners LLP | 0.7% | 09/05/2024 |
| Latest Bid : 42.50p | Latest Ask : 43.00p |
| High Today : 43.62p | Low Today : 42.58p |
| This Years High : 159.60p | This Years Low : 42.58p |
| Volume : 314,131 | MKT Cap : £154.37M |
Avacta Group Overview
Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION platforms.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Avacta Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Deutsche Bank | Premium Only | 2024-05-07 06:47:00 07/05/2024 | 5.49% |
| Sell | Lucian Miers | Premium Only | 2023-12-24 13:45:00 24/12/2023 | 61.43% |
| Avoid | Kevin Godbold | Premium Only | 2022-10-24 15:35:00 24/10/2022 | 57.43% |
| Sell | Tom Winnifrith | Premium Only | 2022-10-18 14:10:00 18/10/2022 | 55.67% |
| Sell | Cat Jeeves | Premium Only | 2022-10-01 17:20:00 01/10/2022 | 59.62% |
Stock Splits and Consolidations
26/01/2016 – Stock Consolidation 100.000:1.000